Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Maughan

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Translational Andrology and Urology|June 10, 2024
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern eraGliceida M Galarza Fortuna, Benjamin L Maughan
Translational Andrology and Urology|June 18, 2025
Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinationsMicah Ostrowski, Georges Gebrael, Benjamin L Maughan
Cancers|May 28, 2022
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary CancersHaoran Li, Kamal K Sahu, Benjamin L Maughan
Cancer Treatment and Research Communications|July 17, 2020
Recent developments in the treatment of non-metastatic castration resistant prostate cancerJohn Esther, Tanya B Dorff, Benjamin L Maughan
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Research and Reports in Urology|December 5, 2018
Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalitiesDeepika Sirohi, Steven C Smith, Neeraj Agarwal, et al.
The Prostate|August 17, 2016
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective StudyBenjamin L Maughan, Brandon Luber, Rosa Nadal, et al.
Frontiers in Oncology|April 20, 2017
Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary CancersBenjamin L Maughan, Erin Bailey, David M Gill, et al.
Human Vaccines & Immunotherapeutics|April 17, 2023
Update on combined immunotherapy for the treatment of advanced renal cell carcinomaGeorges Gebrael, Kamal Kant Sahu, Neeraj Agarwal, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Translational Andrology and Urology|June 10, 2024
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern eraGliceida M Galarza Fortuna, Benjamin L Maughan
Translational Andrology and Urology|June 18, 2025
Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinationsMicah Ostrowski, Georges Gebrael, Benjamin L Maughan
Cancers|May 28, 2022
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary CancersHaoran Li, Kamal K Sahu, Benjamin L Maughan
Cancer Treatment and Research Communications|July 17, 2020
Recent developments in the treatment of non-metastatic castration resistant prostate cancerJohn Esther, Tanya B Dorff, Benjamin L Maughan
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancer Management and Research|June 18, 2020
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular CarcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Research and Reports in Urology|December 5, 2018
Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalitiesDeepika Sirohi, Steven C Smith, Neeraj Agarwal, et al.
The Prostate|August 17, 2016
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective StudyBenjamin L Maughan, Brandon Luber, Rosa Nadal, et al.
Frontiers in Oncology|April 20, 2017
Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary CancersBenjamin L Maughan, Erin Bailey, David M Gill, et al.
Human Vaccines & Immunotherapeutics|April 17, 2023
Update on combined immunotherapy for the treatment of advanced renal cell carcinomaGeorges Gebrael, Kamal Kant Sahu, Neeraj Agarwal, et al.
Pageof 12